HAN Jie, YU Hong. Progress in Immune Markers and Relevant Drug Therapies of Mycosis Fungoides[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 568-574. DOI: 10.12290/xhyxzz.20200278
Citation: HAN Jie, YU Hong. Progress in Immune Markers and Relevant Drug Therapies of Mycosis Fungoides[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 568-574. DOI: 10.12290/xhyxzz.20200278

Progress in Immune Markers and Relevant Drug Therapies of Mycosis Fungoides

  • Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma. The pathogenesis is closely associated with immunological abnormalities. Some novel drugs have emerged recently, especially molecular targeted drugs, which are related to the immune markers of MF. Here we summarized the progress of its immune markers and related drug therapies.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return